Visualize HL7 Example and Test Instances (vi7eti)

Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/

Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.

BACK TO LIST

Patient
Name:	Andresen, , Helene,
DOB:	17-OCT-1939 (Age: 86)
Gender:	female
Address:	Kristiansenberget 2 0172 Sørensen (Norway)
ID:	3450-170343-2 (ECI)

Report
Date:	04-OCT-2015

Laboratory
dr Ample, Ex Laboratoire Central Européenne Boulevard du Jardin Botanique 32 1000 Brussels (Belgium)

Requested by
Oslo universitetssykehus (Ullevål) 0155 Oslo (Norway)

Specimen
Collected:	03-OCT-2015

Hematology

Test	04-OCT-2015	Reference Range	Unit
Leukocytes [#/volume] in Blood by Automated count	4.3	3.4 - 10.6	10*3/uL
Erythrocytes [#/volume] in Blood by Automated count	5.1	4.7 - 5.2	10*6/uL
Hemoglobin [Mass/volume] in Blood	12.8	11.5 - 16	g/dL
Hematocrit [Volume Fraction] of Blood by Automated count	39.3	38 - 56	%
MCV [Entitic volume] by Automated count	83.3	78 - 98	fL
MCH [Entitic mass] by Automated count	32.1	27 - 34	pg
MCHC [Mass/volume] by Automated count	33.4	31 - 36	g/dL
Erythrocyte distribution width [Entitic volume] by Automated count	43.1	36 - 55	fL
Platelets [#/volume] in Blood by Automated count	273.0	150 - 450	10*3/uL
Platelet distribution width [Entitic volume] in Blood by Automated count	319.5 H	11.6 - 17.4	fL
Platelet mean volume [Entitic volume] in Blood by Automated count	11.8	7.2 - 13.5	fL

Chemistry

Test	04-OCT-2015	Reference Range	Unit
Hemoglobin A1c/Hemoglobin.total in Blood	5.9	4.5 - 6.4	%
Glucose [Mass/volume] in Blood	64.6 L	70 - 140	mg/dL
Urea nitrogen [Mass/volume] in Blood	10.7	7 - 25	mg/dL
Creatinine [Mass/volume] in Blood	0.6	0.6 - 1.1	mg/dL
Calcium [Mass/volume] in Blood	9.5	8.6 - 10.4	mg/dL
Sodium [Moles/volume] in Blood	143.7	135 - 145	mmol/L
Potassium [Moles/volume] in Blood	4.2	3.5 - 5.3	mmol/L
Chloride [Moles/volume] in Blood	107.2	98 - 108	mmol/L
Carbon dioxide, total [Moles/volume] in Blood	22.5	22 - 32	mmol/L
Cholesterol [Mass/volume] in Serum or Plasma	182.0	125 - 200	mg/dL
Triglyceride [Mass/volume] in Serum or Plasma	120.5	10 - 175	mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay	97.3	0 - 130	mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma	60.6	50 - 100	mg/dL

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
Laboratory results are largely within normal limits. Notable findings include mild hypoglycemia (glucose 64.6 mg/dL) and elevated platelet distribution width, which may suggest increased platelet size variability but is of unclear clinical significance in isolation. No evidence of renal, hepatic, or significant hematologic dysfunction. Lipid and glycemic control appear adequate. Correlate hypoglycemia clinically.

Conclusion and Recommendations based on this report and previous findings known to us

Laboratory results are largely within normal limits. Notable findings include mild hypoglycemia (glucose 64.6 mg/dL) and elevated platelet distribution width, which may suggest increased platelet size variability but is of unclear clinical significance in isolation. No evidence of renal, hepatic, or significant hematologic dysfunction. Lipid and glycemic control appear adequate. Correlate hypoglycemia clinically.